BOSSI, Paolo
BOSSI, Paolo
Dipartimento di Specialità Medico-Chirurgiche, Scienze Radiologiche e Sanità Pubblica
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1]
2003-01-01 Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L.
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study
2021-01-01 Corino, V. D. A.; Bologna, M.; Calareso, G.; Licitra, L.; Ghi, M.; Rinaldi, G.; Caponigro, F.; Morelli, F.; Airoldi, M.; Allegrini, G.; Cassano, A.; Ferrari, D.; Mirabile, A.; Tosoni, A.; Galizia, D.; Merlano, M.; Sponghini, A.; Moretti, G.; Mainardi, L.; Bossi, P.
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy
2021-01-01 Bozzetti, F.; Gurizzan, C.; Lal, S.; Van Gossum, A.; Wanten, G.; Golusinski, W.; Hosal, S.; Bossi, P.
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes
2019-01-01 De Cecco, L.; Serafini, M. S.; Facco, C.; Granata, R.; Orlandi, E.; Fallai, C.; Licitra, L.; Marchesi, E.; Perrone, F.; Pilotti, S.; Quattrone, P.; Piazza, C.; Sessa, F.; Turri-Zanoni, M.; Battaglia, P.; Castelnuovo, P.; Antognoni, P.; Canevari, S.; Bossi, P.
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
2020-01-01 Ingargiola, Rossana; De Santis, Maria Carmen; Iacovelli, Nicola Alessandro; Facchinetti, Nadia; Cavallo, Anna; Ivaldi, Eliana; Dispinzieri, Michela; Franceschini, Marzia; Giandini, Carlotta; Romanello, Domenico Attilio; Di Biaso, Simona; Sabetti, Michela; Locati, Laura; Alfieri, Salvatore; Bossi, Paolo; Guglielmo, Mauro; Macchi, Fabio; Lozza, Laura; Valdagni, Riccardo; Fallai, Carlo; Pignoli, Emanuele; Orlandi, Ester
A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new?
2006-01-01 Licitra, L.; Bossi, P.; Locati, L. D.
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
2020-01-01 Bossi, P.; Airoldi, M.; Aloe, Spiriti; M. A., Antonuzzo; A., Bonciarelli; G., Campagna; A., Cassano; A., Murialdo; R., Musio; D., Silvano
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC)
2010-01-01 Locati, Ld; Porcu, L; Seregni, E; Granata, R; Bossi, P; Bergamini, C; Mirabile, A; Torri, V; Bombardieri, E; Licitra, L
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact
2016-01-01 Locati, Ld; Perrone, F; Cortelazzi, B; Bergamini, C; Bossi, P; Civelli, E; Morosi, C; Lo Vullo, S; Imbimbo, M; Quattrone, P; Dagrada, Gp; Granata, R; Resteghini, C; Mirabile, A; Alfieri, S; Orlandi, E; Mariani, L; Saibene, G; Pilotti, S; Licitra, L
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy
2019-01-01 Zini, E. M.; Lanzola, G.; Quaglini, S.; Bossi, P.; Licitra, L.; Resteghini, C.
A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer
2020-01-01 Guglielmo, M.; Di Pede, P.; Alfieri, S.; Bergamini, C.; Platini, F.; Ripamonti, C. I.; Orlandi, E.; Iacovelli, N. A.; Licitra, L.; Maddalo, M.; Bossi, P.
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia
2021-01-01 Iacovelli, N. A.; Ingargiola, R.; Facchinetti, N.; Franceschini, M.; Romanello, D. A.; Bossi, P.; Bergamini, C.; Alfieri, S.; Cavalieri, S.; Baron, G.; Aldini, G.; Locati, L.; Orlandi, E.
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
2017-01-01 Bossi, P.; Cortinovis, D.; Fatigoni, S.; Cossu Rocca, M.; Fabi, A.; Seminara, P.; Ripamonti, C.; Alfieri, S.; Granata, R.; Bergamini, C.; Agustoni, F.; Bidoli, P.; Nole, F.; Pessi, M. A.; Macchi, F.; Michellini, L.; Montanaro, F.; Roila, F.
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
2017-01-01 Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L.
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial
2021-01-01 Locati, Laura D; Cavalieri, Stefano; Bergamini, Cristiana; Resteghini, Carlo; Colombo, Elena; Calareso, Giuseppina; Mariani, Luigi; Quattrone, Pasquale; Alfieri, Salvatore; Bossi, Paolo; Platini, Francesca; Capone, Iolanda; Licitra, Lisa
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma
2016-01-01 Perrone, F; Bossi, P; Cortelazzi, B; Dagrada, Gp; Paielli, N; Licitra, L; Pilotti, S
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic
2021-01-01 Gurizzan, C.; Pedersini, R.; Fornaro, C.; Sardini, C.; Zamparini, M.; Monteverdi, S.; Tovazzi, V.; Cosentini, D.; Dalla Volta, A.; Baggi, A.; Turla, A.; Di Mauro, P.; Lorini, L.; Lagana, M.; Bianchi, S.; Grisanti, S.; Consoli, F.; Conti, E.; Bossi, P.; Berruti, A.
Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma
2013-01-01 Bossi, P; Perrone, F; Cortelazzi, B; Licitra, L
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN)
2018-01-01 Machiels, J. -P.; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F.
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy
2014-01-01 Locati, Ld; Perrone, F; Cortelazzi, B; Imbimbo, M; Bossi, P; Potepan, P; Civelli, E; Rinaldi, G; Quattrone, P; Licitra, L; Pilotti, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] | 1-gen-2003 | Locati, L. D.; Quattrone, P.; Bossi, P.; Marchiano, A. V.; Cantu, G.; Licitra, L. | |
| A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study | 1-gen-2021 | Corino, V. D. A.; Bologna, M.; Calareso, G.; Licitra, L.; Ghi, M.; Rinaldi, G.; Caponigro, F.; Morelli, F.; Airoldi, M.; Allegrini, G.; Cassano, A.; Ferrari, D.; Mirabile, A.; Tosoni, A.; Galizia, D.; Merlano, M.; Sponghini, A.; Moretti, G.; Mainardi, L.; Bossi, P. | |
| A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy | 1-gen-2021 | Bozzetti, F.; Gurizzan, C.; Lal, S.; Van Gossum, A.; Wanten, G.; Golusinski, W.; Hosal, S.; Bossi, P. | |
| A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes | 1-gen-2019 | De Cecco, L.; Serafini, M. S.; Facco, C.; Granata, R.; Orlandi, E.; Fallai, C.; Licitra, L.; Marchesi, E.; Perrone, F.; Pilotti, S.; Quattrone, P.; Piazza, C.; Sessa, F.; Turri-Zanoni, M.; Battaglia, P.; Castelnuovo, P.; Antognoni, P.; Canevari, S.; Bossi, P. | |
| A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients | 1-gen-2020 | Ingargiola, Rossana; De Santis, Maria Carmen; Iacovelli, Nicola Alessandro; Facchinetti, Nadia; Cavallo, Anna; Ivaldi, Eliana; Dispinzieri, Michela; Franceschini, Marzia; Giandini, Carlotta; Romanello, Domenico Attilio; Di Biaso, Simona; Sabetti, Michela; Locati, Laura; Alfieri, Salvatore; Bossi, Paolo; Guglielmo, Mauro; Macchi, Fabio; Lozza, Laura; Valdagni, Riccardo; Fallai, Carlo; Pignoli, Emanuele; Orlandi, Ester | |
| A multidisciplinary approach to squamous cell carcinomas of the head and neck: What is new? | 1-gen-2006 | Licitra, L.; Bossi, P.; Locati, L. D. | |
| A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches | 1-gen-2020 | Bossi, P.; Airoldi, M.; Aloe, Spiriti; M. A., Antonuzzo; A., Bonciarelli; G., Campagna; A., Cassano; A., Murialdo; R., Musio; D., Silvano | |
| A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) | 1-gen-2010 | Locati, Ld; Porcu, L; Seregni, E; Granata, R; Bossi, P; Bergamini, C; Mirabile, A; Torri, V; Bombardieri, E; Licitra, L | |
| A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact | 1-gen-2016 | Locati, Ld; Perrone, F; Cortelazzi, B; Bergamini, C; Bossi, P; Civelli, E; Morosi, C; Lo Vullo, S; Imbimbo, M; Quattrone, P; Dagrada, Gp; Granata, R; Resteghini, C; Mirabile, A; Alfieri, S; Orlandi, E; Mariani, L; Saibene, G; Pilotti, S; Licitra, L | |
| A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy | 1-gen-2019 | Zini, E. M.; Lanzola, G.; Quaglini, S.; Bossi, P.; Licitra, L.; Resteghini, C. | |
| A randomized, double-blind, placebo controlled, phase II study to evaluate the efficacy of ginseng in reducing fatigue in patients treated for head and neck cancer | 1-gen-2020 | Guglielmo, M.; Di Pede, P.; Alfieri, S.; Bergamini, C.; Platini, F.; Ripamonti, C. I.; Orlandi, E.; Iacovelli, N. A.; Licitra, L.; Maddalo, M.; Bossi, P. | |
| A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia | 1-gen-2021 | Iacovelli, N. A.; Ingargiola, R.; Facchinetti, N.; Franceschini, M.; Romanello, D. A.; Bossi, P.; Bergamini, C.; Alfieri, S.; Cavalieri, S.; Baron, G.; Aldini, G.; Locati, L.; Orlandi, E. | |
| A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin | 1-gen-2017 | Bossi, P.; Cortinovis, D.; Fatigoni, S.; Cossu Rocca, M.; Fabi, A.; Seminara, P.; Ripamonti, C.; Alfieri, S.; Granata, R.; Bergamini, C.; Agustoni, F.; Bidoli, P.; Nole, F.; Pessi, M. A.; Macchi, F.; Michellini, L.; Montanaro, F.; Roila, F. | |
| A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck | 1-gen-2017 | Bossi, P.; Miceli, R.; Locati, L. D.; Ferrari, D.; Vecchio, S.; Moretti, G.; Denaro, N.; Caponigro, F.; Airoldi, M.; Moro, C.; Vaccher, E.; Sponghini, A.; Caldara, A.; Rinaldi, G.; Ferrau, F.; Nole, F.; Lo Vullo, S.; Tettamanzi, F.; Hollander, L.; Licitra, L. | |
| Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial | 1-gen-2021 | Locati, Laura D; Cavalieri, Stefano; Bergamini, Cristiana; Resteghini, Carlo; Colombo, Elena; Calareso, Giuseppina; Mariani, Luigi; Quattrone, Pasquale; Alfieri, Salvatore; Bossi, Paolo; Platini, Francesca; Capone, Iolanda; Licitra, Lisa | |
| Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma | 1-gen-2016 | Perrone, F; Bossi, P; Cortelazzi, B; Dagrada, Gp; Paielli, N; Licitra, L; Pilotti, S | |
| Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic | 1-gen-2021 | Gurizzan, C.; Pedersini, R.; Fornaro, C.; Sardini, C.; Zamparini, M.; Monteverdi, S.; Tovazzi, V.; Cosentini, D.; Dalla Volta, A.; Baggi, A.; Turla, A.; Di Mauro, P.; Lorini, L.; Lagana, M.; Bianchi, S.; Grisanti, S.; Consoli, F.; Conti, E.; Bossi, P.; Berruti, A. | |
| Acquired resistance to Hedgehog inhibitor through smoothened mutation in basal cell carcinoma | 1-gen-2013 | Bossi, P; Perrone, F; Cortelazzi, B; Licitra, L | |
| Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) | 1-gen-2018 | Machiels, J. -P.; Bossi, P.; Menis, J.; Lia, M.; Fortpied, C.; Liu, Y.; Lhommel, R.; Lemort, M.; Schmitz, S.; Canevari, S.; De Cecco, L.; Guzzo, M.; Bianchi, R.; Quattrone, P.; Crippa, F.; Duprez, T.; Lalami, Y.; Quiriny, M.; de Saint Aubain, N.; Clement, P. M.; Coropciuc, R.; Hauben, E.; Licitra, L. F. | |
| Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy | 1-gen-2014 | Locati, Ld; Perrone, F; Cortelazzi, B; Imbimbo, M; Bossi, P; Potepan, P; Civelli, E; Rinaldi, G; Quattrone, P; Licitra, L; Pilotti, S |